Glycemic Control and Hypoglycemia in Patients Treated with Insulin Pump Therapy: An Observational Study
Table 2
Characteristics of patients after the initiation of insulin pump therapy.
Variable
Measure
Time with insulin pump therapy (months)
24 (18-49)
Weight (kg)
64 (56-72)
BMI
24.8 (22.25-27.5)
HbA1c posterior to the initiation of IPT (%)
7.5 (6.9–8.1)
Insulin dose (IU)
37 (27.4-51.1)
Use of continuous glucose sensor (%)
80.3
Distribution of insulin use
Basal
51 (43-57)
Boluses
49 (43-57)
Units of basal insulin
4 (3-5)
Units of correction insulin
90 (67.4-96.6)
Overcorrection
Yes
7 (13.7)
Not
44 (86.2)
Coefficient of variability (%)
SD of glucose measures calculated by CGM (mg/dL)
Complications associated to the use of IPT
None
28 (55.5)
Irritation at the catheter insertion site
12 (23)
Infection at the catheter insertion site
6 (11.7)
Diabetic ketoacidosis
5 (9.8)
Reported as mean value (standard deviation). Values reported as absolute number, (percentage). Reported as median (interquartile range). BMI: body mass index; HbA1c: glycosylated hemoglobin; IPT: insulin pump therapy; IU: international units; SD: standard deviation.